Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1255873
Max Phase: Preclinical
Molecular Formula: C121H200N38O26
Molecular Weight: 2603.17
Molecule Type: Protein
Associated Items:
ID: ALA1255873
Max Phase: Preclinical
Molecular Formula: C121H200N38O26
Molecular Weight: 2603.17
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C
Standard InChI: InChI=1S/C121H200N38O26/c1-16-68(10)95(114(181)149-78(43-30-50-134-118(126)127)101(168)139-62-92(162)138-63-93(163)144-79(44-31-51-135-119(128)129)102(169)141-69(11)97(164)140-71(13)99(166)156-94(67(8)9)113(180)153-85(56-65(4)5)110(177)152-88(61-91(125)161)108(175)143-72(14)117(184)185)157-105(172)83(46-33-53-137-121(132)133)145-98(165)70(12)142-107(174)86(59-75-37-22-18-23-38-75)151-111(178)87(60-76-39-24-19-25-40-76)150-104(171)80(41-26-28-48-122)146-103(170)82(45-32-52-136-120(130)131)147-109(176)84(55-64(2)3)154-115(182)96(73(15)160)158-106(173)81(42-27-29-49-123)148-112(179)90-47-34-54-159(90)116(183)89(57-66(6)7)155-100(167)77(124)58-74-35-20-17-21-36-74/h17-25,35-40,64-73,77-90,94-96,160H,16,26-34,41-63,122-124H2,1-15H3,(H2,125,161)(H,138,162)(H,139,168)(H,140,164)(H,141,169)(H,142,174)(H,143,175)(H,144,163)(H,145,165)(H,146,170)(H,147,176)(H,148,179)(H,149,181)(H,150,171)(H,151,178)(H,152,177)(H,153,180)(H,154,182)(H,155,167)(H,156,166)(H,157,172)(H,158,173)(H,184,185)(H4,126,127,134)(H4,128,129,135)(H4,130,131,136)(H4,132,133,137)/t68-,69-,70-,71-,72-,73-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,94-,95-,96-/m0/s1
Standard InChI Key: IFBIGSDYFSGUQP-FECNYNEWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 2603.17 | Molecular Weight (Monoisotopic): 2601.5496 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Reynolds NL, De Cecco M, Taylor K, Stanton C, Kilanowski F, Kalapothakis J, Seo E, Uhrin D, Campopiano D, Govan J, Macmillan D, Barran P, Dorin JR.. (2010) Peptide fragments of a beta-defensin derivative with potent bactericidal activity., 54 (5): [PMID:20176896] [10.1128/aac.01568-09] |
Source(1):